Schmertzler Michael's Form 4 filing
PTC Therapeutics, Inc. (PTCT) · filed Aug 28, 2026
- Accession no.
- 0001288952-26-000006
- Filed
- Aug 28, 2026, 5:20 PM ET
- Trade date
- Aug 26-27, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.81M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Schmertzler MichaelCIK 0001288952 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 26, 2026 | Common Stock | SSaleDisposed | −6,874 | $72.74 | −$500,014.76 | 1,354,720 | Indirect | |
| Aug 26, 2026 | Common Stock | SSaleDisposed | −5,626 | $73.18 | −$411,710.68 | 1,349,094 | Indirect | |
| Aug 27, 2026 | Common Stock | SSaleDisposed | −11,890 | $71.55 | −$850,729.5 | 1,337,204 | Indirect | |
| Aug 27, 2026 | Common Stock | SSaleDisposed | −610 | $72.22 | −$44,054.2 | 1,336,594 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.